Evaluate Tocilizumab Alternatives for COVID-19
October 2021
Tocilizumab (Actemra) shortages will continue to raise questions about using an add-on to steroids for COVID-19.
This IL-6 inhibitor is the go-to add-on. But supplies are low...plus hospitals are balancing stock for other indications.
Continue to apply creative solutions. For example, if you have tocilizumab subcutaneous prefilled syringes, consider using them to make IV doses...lab data suggest similar stability. Infuse with a filter.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote